Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Colorectal Neoplasms 5Multiple Myeloma 4Barrett Esophagus 3Venous Thromboembolism 2Tobacco Use Disorder 2Prostatic Neoplasms 2Precancerous Conditions 2Polycythemia Vera 2Myocardial Infarction 2Esophageal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Triple Negative Breast Neoplasms 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stroke 1Soft Tissue Neoplasms 1Smoking Cessation 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Pulmonary Nodules 1

Interventions

Paclitaxel 96Carboplatin 81Bevacizumab 62Gemcitabine 36liposomal doxorubicin 32pembrolizumab 30Topotecan 26olaparib 23Taxes 23niraparib 17Immunoglobulin G 17Disulfides 17Docetaxel 16Cyclophosphamide 16Cisplatin 14Nivolumab 11rucaparib 10durvalumab 10Doxorubicin 9Albumin-Bound Paclitaxel 8sargramostim 7pazopanib 7fludarabine phosphate 7fludarabine 7avelumab 7Magnetic Resonance Spectroscopy 7Ifosfamide 7epacadostat 6Trabectedin 6Sorafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Ovarian Neoplasms × Aspirin × Clear all
NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

Phase 4 Completed
19 enrolled 10 charts
Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡